Alibaba Health Information Technology Limited (HKG:0241)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.590
+0.060 (1.70%)
Jul 31, 2026, 4:08 PM HKT

HKG:0241 Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, HKG:0241 stock has a consensus rating of "Buy" and an average price target of $5.38. The average 1-year stock price forecast is 49.86% higher than the current stock price, while the lowest is $3.11 (-13.37%) and the highest is $8.06 (+124.51%).

Price Target: $5.38 (+49.86%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$3.11$5.38$5.12$8.06
Change-13.37%+49.86%+42.62%+124.51%
* Price targets were last updated on May 19, 2026.

Analyst Ratings

The average analyst rating for HKG:0241 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingFeb '26Mar '26Apr '26May '26Jun '26Jul '26
Strong Buy10101010108
Buy111111
Hold555554
Sell000000
Strong Sell222222
Total181818181815

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Jefferies
Jefferies
Buy
Maintains
$5.30
BuyMaintains$5.30+47.63%May 19, 2026
Goldman Sachs
Goldman Sachs
Hold
Maintains
$4.80$4.20
HoldMaintains$4.80$4.20+16.99%May 19, 2026
Unknown Analyst
Huatai Securities
No rating
Huatai Securities
Buy
Maintains
$5.66$4.92
BuyMaintains$5.66$4.92+37.05%May 19, 2026
Unknown Analyst
CICC
No rating
CICC
Buy
Maintains
$6.50
BuyMaintains$6.50+81.06%May 17, 2026
Morgan Stanley
Morgan Stanley
Sell
Maintains
$4.20
SellMaintains$4.20+16.99%May 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
38.55B
from 34.26B
Increased by 12.54%
Revenue Next Year
42.76B
from 38.55B
Increased by 10.93%
EPS This Year
0.14
from 0.14
Decreased by -0.06%
EPS Next Year
0.17
from 0.14
Increased by 19.85%
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingMar 31, 2022Mar 31, 2023Mar 31, 2024Mar 31, 2025Mar 31, 2026Mar 31, 2027
Revenue
20.58B26.76B27.03B30.60B34.26B38.55B
Revenue Growth
32.60%30.06%0.99%13.22%11.95%12.54%
Gross Profit
4.11B5.70B5.90B7.43B8.21B9.20B
Gross Margin
19.96%21.30%21.81%24.29%23.97%23.87%
Operating Income
-1.10B-51.50M634.85M1.45B1.83B2.24B
Net Income
-265.56M535.65M883.48M1.43B1.94B2.14B
EPS
----0.140.14
EPS Growth
----18.78%-0.06%
Forward PE
298.27177.5138.5434.3224.3621.53
Dividend / Share
----0.060.03
Free Cash Flow
700.89M-19.58M318.76M693.25M599.96M2.66B
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202720282029
High39.4B
Avg38.5B
Low37.9B

Revenue Growth

Revenue Growth202720282029
High
15.2%
Avg
12.5%
Low
10.6%

EPS Forecast

EPS202720282029
High0.17
Avg0.14
Low0.13

EPS Growth

EPS Growth202720282029
High
15.1%
Avg
-0.1%
Low
-6.1%